Heyholder
‹ Activism Filings

CELL BIOTECH CO ., LTD Q3 profit from main business KRW 2.0 billion on sales of KRW 14.8 billion

CELL BIOTECH CO ., LTD· Periodic Report

AI summary · Not investment advice

Cell Biotech sold KRW 14.8 billion worth in Q3 and earned KRW 2.0 billion from its main business, down 9.4% from a year earlier.

Operating profit · 3 months

KRW 2.0 billion

Key facts

Revenue (3 months)
KRW 14.8 billion
Net income (3 months)
KRW -4.3 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 15.4 billion
Revenue (year to date)
KRW 45.3 billion
Operating profit (prior-year 3 months)
KRW 2.2 billion
Operating profit (year to date)
KRW 6.8 billion
Net income (prior-year 3 months)
KRW 3.4 billion
Net income (year to date)
KRW 4.7 billion

Commentary

AI commentary · Not investment advice

What happened

Cellbiotech reported its consolidated results for the third quarter of 2026 in a quarterly report. Sales for the latest 3 months were KRW 14.85 billion. That is 3.3% lower than the same 3 months a year earlier (KRW 15.36 billion).

In the company's terms

Operating profit (money earned from the core business) was KRW 2.01 billion for the 3 months. That is 9.4% lower than a year earlier (KRW 2.22 billion). Net income (the final profit after taxes and other costs) was a loss of KRW 4.27 billion for the 3 months. A year earlier it was a profit of KRW 3.45 billion, so it turned into a loss.

What changes for shareholders

For the cumulative period from January 1 to September 30, sales were KRW 45.26 billion. Operating profit was KRW 6.83 billion. Net income was KRW 4.69 billion.

Comments

No comments yet

Comments from shareholders will appear here.